News - Latest
44 news items
Sort by: Date / Relevance
MEB Annual Report 2021: Looking ahead
The coronavirus had a big impact on the year 2021, just like it did in 2020. It made 2021 very special year once again. In the ...
Amended policy on national implementation of additional risk minimisation measures
The Medicines Evaluation Board (MEB) has amended its policy for the national implementation of additional risk minimisation ...
Regulatory Science Magazine on academic drug development
The academic world plays a key role in drug discovery and development. However, bringing drugs to market is challenging and ...
Medicines available faster due to simultaneous assessment
The National Health Care Institute joined forces with the Medicines Evaluation Board to develop a method that would give patients ...
The growing importance of patient registers for the assessment of medicines
Research by the Julius Center (a division of UMC Utrecht), UMC Groningen and the Medicines Evaluation Board reveals that patient ...
European Commission publishes statement on interpretation of Article 152, paragraph 2
The European Commission has listened to concerns regarding a difference in interpretation of the transitional provision in ...
Improvements to the notification process and form now available
In December 2021 the Medicines Evaluation Board and the Health and Youth Care Inspectorate announced the introduction of changes ...
MEB fee rate change as of January 2022
The Medicines Evaluation Board (MEB) increases the fee rates for authorisation applications, authorisation changes and the annual ...
Changes to policy on product information
The Medicines Evaluation Board (MEB) has recently revised two policy documents for pharmaceutical companies in respect of the ...
New reporting process for the Medicine Shortages and Defects Notification Centre
With effect from 1 January 2022, the Medicines Evaluation Board and the Health and Youth Care Inspectorate will be introducing ...